Patents Assigned to The University of Regensburg
  • Patent number: 9631001
    Abstract: The invention relates to a new group of snake venom basic protease inhibitors having vasopressin-2 receptor antagonist activity that can be used in therapy, diagnosis, medical imaging, drug screening and research.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: April 25, 2017
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITY OF REGENSBURG, UNIVERSITY DE LIEGE
    Inventors: Nicolas Gilles, Denis Servent, Loïc Quinton, Helen Reinfrank, Ralph Witzgall, Bernard Mouillac, Christiane Mendre
  • Patent number: 8278087
    Abstract: The present invention relates to the field of degradation with hyperthermophilic organisms, and in particular to the use of hyperthermophilic degradation to produce heat and energy rich components including hydrogen and ethanol from a biomass. In some embodiments, a biomass is fermented in the presence of hyperthermophilic organisms to produce heat. The heat is used to heat a liquid which is used directly in a heat pump or radiant heat or to produce electricity or drive a steam turbine. In some embodiments, acetate is utilized as a substrate to produce energy by methanogenesis.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: October 2, 2012
    Assignee: The University of Regensburg
    Inventors: Jan Remmereit, Michael Thomm
  • Publication number: 20120196286
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene
    Type: Application
    Filed: March 28, 2012
    Publication date: August 2, 2012
    Applicant: UNIVERSITY OF REGENSBURG
    Inventors: Bernhard H.F. Weber, Thomas Loenhardt, Andrea Milenkovic, Lars G. Fritsche
  • Patent number: 8168390
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: May 1, 2012
    Assignee: University of Regensburg
    Inventors: Bernhard H. F. Weber, Thomas Loenhardt, Andrea Milenkovic, Lars G. Fritsche
  • Publication number: 20100304369
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing age-related macular degeneration comprising detecting an insertion/deletion polymorphism in the ARMS2 gene
    Type: Application
    Filed: May 27, 2009
    Publication date: December 2, 2010
    Applicant: UNIVERSITY OF REGENSBURG
    Inventors: Bernhard H.F. Weber, Thomas Loenhardt, Andrea Milenkovic, Lars G. Fritsche